Jacobs School of Medicine
and Biomedical Sciences

A pair of research studies led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, reveal important new findings as to how regeneration of myelin in multiple sclerosis (MS) fails and, potentially, more efficient ways to treat it.

The honors continue for Limitless Medical Technologies (LMT), a University at Buffalo startup which produces a leak-sensing film that works with an app to monitor patients who have had intestinal repairs.

Chelsie E. Armbruster, PhD, and Elsa Bou Ghanem, PhD, both assistant professors of microbiology and immunology, are being recognized as highly-promising, early-career scientists in the field of host-microbe interactions by the American Society for Microbiology’s Infection and Immunity (IAI) Journal.

Researchers from the Jacobs School of Medicine and Biomedical Sciences have found evidence of the so-called California variants of COVID-19 — B.1.427 and B.1.429 — in virus samples of Western New Yorkers who tested positive in January by using genetic sequencing to decode the genes of SARS-CoV-2 and better understand how it is evolving.